Enigma Diagnostics appoints Professor Christopher Lowe as non-executive director

22-Dec-2006

Enigma Diagnostics, a Life Sciences company developing rapid molecular diagnostics systems, announced the appointment of Professor Christopher Lowe as Non-executive Director. Professor Lowe is Director of the Institute of biotechnology at the University of Cambridge. He is a Fellow of the Royal Academy of Engineering, the Institute of Physics and the Royal Society of chemistry.

Over the past 30 years, Prof. Lowe has focused on the development of pharmaceuticals, fine chemicals and diagnostics based on a highly inter- and multi-disciplinary approach. His approach combines aspects of biochemistry, microbiology, chemistry, electrochemistry, physics, electronics, medicine and chemical engineering, and from pure science to strategic applied science to the development of commercial applications.

Other news from the department people

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper